To assess this possibility we contrasted the receiver operating characteristics (ROC) for the five analytes with the highest fold-difference between ALN and ANLN, with previously proposed urinary and serum (C3, anti-dsDNA) biomarkers, as well as established markers of renal dysfunction (Table 3; see Additional file 1: Figure S1). The gene discussed is C3; the disease is Abnormal renal physiology.